Susquehanna International Group, LLP Can Fite Bio Pharma Ltd. Transaction History

Susquehanna International Group, LLP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$0.6 - $8.94 $15,981 - $238,116	-26,635 Reduced 44.86%	32,739 $19,000
Q3 2022 Nov 14, 2022	BUY	$0.74 - $7.9 $9,400 - $100,361	12,704 Added 27.22%	59,374 $46,000
Q2 2022 Aug 15, 2022	BUY	$0.83 - $1.24 $38,736 - $57,870	46,670 New	46,670 $43,000
Q1 2021 May 17, 2021	SELL	$1.8 - $2.92 $27,581 - $44,743	-15,323 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$1.66 - $2.15 $25,436 - $32,944	15,323 New	15,323 $27,000
Q4 2019 Feb 14, 2020	SELL	$1.95 - $4.4 $95,862 - $216,304	-49,160 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$2.06 - $3.3 $101,269 - $162,228	49,160 New	49,160 $101,000

1.1K

Ticker CANF
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 27,191,500
Market Cap $44.6M
Description
Can-Fite BioPharma Ltd., a clinical-stage biopharmaceutical company, develops small molecule therapeutic products for the treatment of cancer, liver inflammatory diseases, and erectile dysfunction. The company's lead drug candidate Piclidenoson, which has been completed Phase III clinical trial for the treatment of psoriasis; and Phase II clinic...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.